Abstract

Misclassification error is a common problem of cancer registries in developing countries that leads to biased cancer rates. The purpose of this research is to use Bayesian method for correcting misclassification in registered cancer incidence of eighteen provinces in Iran. Incidence data of patients with colorectal cancer were extracted from Iranian annual of national cancer registration reports from 2005 to 2008. A province with proper medical facilities can always be compared to its neighbors. Almost 28% of the misclassification was estimated between the province of East Azarbaijan and West Azarbaijan, 56% between Fars and Hormozgan, 43% between Isfahan and Charmahal and Bakhtyari, 46% between Isfahan and Lorestan, 58% between Razavi Khorasan and North Khorasan, 50% between Razavi Khorasan and South Khorasan, 74% between Razavi Khorasan and Sistan and Balochestan, 43% between Mazandaran and Golestan, 37% between Tehran and Qazvin, 45% between Tehran and Markazi, 42% between Tehran and Qom, 47% between Tehran and Zanjan. Correcting the regional misclassification and obtaining the correct rates of cancer incidence in different regions is necessary for making cancer control and prevention programs and in healthcare resource allocation.

Highlights

  • Colorectal cancer (CRC) is the third most common cancer among men (10.0% of the total) and the second in women (9.2% of the total) worldwide

  • The aim of this study is to investigate the trend of colorectal cancer provinces in Iran after estimating the misclassification rate in registering cancer incidence by using Bayesian method and re-estimating the incidence rate in each province

  • Colorectal cancer trend in Iranian provinces notable matter in medicine which may results in deflecting of health programing and health resources allocation [28]

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common cancer among men (10.0% of the total) and the second in women (9.2% of the total) worldwide. Mortality is lower (694,000 deaths, 8.5% of the total) with more deaths (52%) in the less developed regions of the world, reflecting a poorer survival in these regions [1]. In Iran, CRC is the fourth most common type of cancer (the third most common cancer among females and the fifth among males), which accounts for 8.4% of total cancers in the country [2,3]. About 55% of the cases take place in more developed regions. It is partly because of their advanced diagnostic and registration capabilities [1]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call